This application relates to methods and devices for disinfecting a fluid, such as water, using ultraviolet radiation.
U.S. Pat. No. 1,196,481, issued Aug. 29, 1916, describes using UV light from a low-pressure mercury lamp for disinfection of water. As is generally accepted in the art, the key to disinfection of water using light is to illuminate the water with sufficient optical energy flux to kill or deactivate live microorganisms in the water. The optical energy flux required for disinfection is dependent on the spectrum of the light source and is generally measured in units of joules per square centimeter (J/cm2). This energy flux is the product of the irradiation intensity in watts per square centimeter (W/cm2) and the irradiation time in seconds, so that improving water throughput in an optical disinfection system requires reducing the required energy flux, increasing optical intensity or increasing irradiation time.
Nucleic acid absorption is well known to peak at approximately 265 nm, declining at longer wavelengths and down by more than a factor of ten at 300 nm. As a result, gas discharge lamps with significant spectral energy at wavelengths below 280 nm were preferred sources for UV disinfection through the 20th century. Cylindrical geometries of such sources, together with the lack of high efficiency reflectors at wavelengths below 280 nm, drove UV disinfection systems to depend on radial optical designs, wherein UV light emitted radially outward from the cylindrical source propagates through fluid outside the source. Radial emission intensity from a cylindrical source diminishes with the square of the distance from the source, typically limiting utilization of the UV from the source to a path length that is well below the UV absorption path length in low-turbidity water. Furthermore, these properties of cylindrical sources mean that a germicidal discharge lamp must be immersed in the water flow path in a practical implementation, requiring a window to protect the lamp from the water and producing issues common to all such systems—including contaminant deposition onto the protective window, the possibility of discharge lamp breakage with resulting mercury contamination of the water, and heating of the fluid by the non-germicidal portion of lamp emission spectra. The disinfection irradiation time in such a cylindrical geometry is limited to the dwell time of the water in passing the cylindrical source. Various methods have been discovered for increasing effective dwell time. For example U.S. Pat. No. 4,255,383, issued Mar. 10, 1981, describes recirculating water through a UV water disinfection system to increase the irradiation time, and U.S. Pat. No. 6,099,799, issued Aug. 8, 2000, describes use of concentric water flow chambers plumbed in series to increase the irradiation time, although this geometry does not significantly improve water throughput.
UVC LEDs (peak emission wavelengths below 280 nm) produce low (˜mW maximum) continuous output power per emitter, at low (<1%) electrical conversion efficiency and with short (<1000 hours) useable lifetimes.
These properties of low electrical conversion efficiency, low output power and short lifetime for existing UVC LEDs remain as obstacles to successful implementation of an LED-based photodisinfection system. As a result, there exists a need to identify more reliable germicidal LED sources, coupled with system designs that efficiently use the emission from available LED sources to produce increased irradiation intensities as well as increased effective irradiation times that meet water treatment throughput requirements.
Disclosed are apparatuses and methods for disinfecting a fluid, such as water, using wavelengths significantly longer than those previously considered germicidal. Wavelengths below 300 nm are well-known to be capable of killing and/or sterilizing microorganisms such as bacteria, viruses and protozoa/cysts, with peak efficacy observed at approximately 265 nm. Ultraviolet radiation at longer wavelengths is absorbed only weakly by microbial entities and has therefore not been considered viable for photodisinfection applications.
Commercially available single-emitter LEDs with peak wavelengths in the 350-400 nm range can produce watts of UV output power with efficiencies >15%. In addition, the optical brightness (optical output power per unit emitting area per unit emitting angle) of these available UVA LED sources is much greater than for a discharge lamp, allowing efficient optical coupling of such light into a treatment vessel. Still further, at UVA wavelengths greater than 315 nm, and especially greater than 350 nm, practical materials that reflect or transmit light include a variety of glasses and polymer materials, and the number of these materials is much greater than those useable below 300 nm. Such materials enable optical designs that can effectively contain light within a treatment vessel so that light intensity I at distance R from a light source diminishes more slowly than the typical 1/R2 intensity decline observed with point or cylindrical light sources. This improves intensity throughout a treatment vessel and allows the treatment vessel to be extended in at least one dimension, increasing treatment volume within the vessel. For example, an extended tubular treatment vessel with a polygonal, elliptical, circular or other cross section can be used to increase dwell times and treatment efficacy. Furthermore, reflective end surfaces in such a treatment vessel can allow light to make multiple round trips within the vessel, raising the intensity within the chamber beyond the intensity achievable with a UVA LED source alone. In the case of treating low-turbidity water, the UVA treatment vessel length and the resulting irradiation dwell time in the treatment vessel are limited fundamentally by the optical absorbance of the water itself. UV-visible optical transmission by pure water is greatest near 400 nm, and is 5-10 times greater in the 350-400 nm portion of the UVA spectrum than in the 250-280 nm range generally considered germicidal. This transmission difference increases with addition of impurities such as salts and organic substances to the water, so that UVA germicidal treatment vessels can be significantly longer than UVC treatment vessels. As a result of these considerations, both irradiation intensities and irradiation times can be larger in the UVA than in the UVC, resulting in UVA germicidal energy fluxes large enough to overcome the efficacy disadvantage arising from the lower UVA germicidal efficiency at the longer wavelengths. Furthermore, UVA radiation is less photochemically active than UVC, reducing the rate at which photolytic processes deposit contaminants from the treated fluid onto the windows and walls of the treatment vessel, and thereby further increasing the reliability of a UVA germicidal system compared with a UVC germicidal system. Still further, lower-cost silicon photodetectors can monitor UVA flux in a treatment vessel through lower-cost windows in vessel walls than are practical with UVC germicidal irradiation technologies.
Embodiments can comprise a treatment vessel with one or more UV LEDs or other compact UV light emitters that irradiate fluid within the vessel through at least one window in the vessel in order to disinfect the fluid. The treatment vessel can comprise a chamber filled with fluid that is treated by the UV irradiation in a batch process. Alternately, the vessel can contain at least one inlet and one outlet so that fluid enters into one portion of the vessel and exits from another portion of the vessel, and so that the UV irradiation acts to disinfect the fluid during its dwell time within the vessel. Desirably, the treatment vessel comprises at least one portion that is tubular in shape, with a length along one dimension greater than its maximum width transverse to the length dimension, and with the light from the one or more compact UV sources directed substantially along this length dimension within this tubular portion of the vessel. Further embodiments can include reflective features on or around this tubular portion of the treatment vessel that constrain ultraviolet radiation directed into the fluid to travel substantially along a length of fluid to be treated, especially within a transverse dimension that is substantially less than this length, and with substantially homogeneous intensity across any cross-section of the treatment length. Still further embodiments can include reflective surfaces at each end of the fluid treatment vessel that can return a fraction of the light propagating along the vessel back into the vessel. By reflecting a significant fraction of the light propagating along this fluid length from each end of the vessel, the flux of light within the fluid is increased, and multiple reflections further increase the flux. Reflecting a fraction ρ of the light incident on each end of the treatment vessel back into the vessel increases the flux of light within the vessel by a factor of up to 1/(1−ρ). For example, a 50% reflection at each end of the treatment vessel can double the effective flux within the vessel. Homogeneity of flux within the liquid, together with increased intensity due to multiple reflections along the length of the illuminated fluid region, can result in increased dose during the contact time of the light with the flowing fluid. Irradiating a fluid substantially along the axis of a tubular treatment vessel, optimizing UV dose through improved optical design, and/or using efficient, high-power UVA LEDs, can render UVA photodisinfection of fluids, including water, practical. In addition, methods for monitoring UVA flux within the treatment vessel are disclosed herein, as can be desirable for assuring system performance.
In a first embodiment, fluid is placed inside an elongated treatment vessel. Ultraviolet radiation from one or more UVA sources enters the fluid through a window or opening in the exterior wall at one end of the elongated vessel and travels along the long axis of the vessel. Each photon, or quantum of UV light, has the opportunity to interact with microbial contaminants along the entire length of the treatment vessel, and the intensity of light at any point within the vessel is inversely proportional to the cross-sectional area of the vessel at that point. For a low-turbidity, UVA-transmitting fluid in the vessel, the quantum efficiency of the disinfection process is approximately proportional to the length of the treatment vessel.
In a second embodiment, the UVA radiation traveling along the long axis of the elongated treatment vessel is reflected by reflective interior surfaces of the vessel walls (such as polished or coated stainless steel), or by a coating or other reflective material outside substantially transparent vessel walls. The UVA radiation intensity can be substantially homogenized across the interior of the treatment vessel as the radiation propagates through the fluid, and reduced loss of light at the side walls of the vessel results in higher UVA radiation intensity along the length of the vessel.
In a third embodiment, one or both end surfaces of the treatment vessel, except for one or more windows large enough to admit the UV from the UVA source or sources, can also be reflective to recirculate the UV radiation back and forth within the treatment vessel and thereby to maximize the UV irradiation flux over the treatment volume. The length of the treatment vessel can be set at the largest practical length to maximize treatment volume within a practical irradiation time. The largest practical length can be determined by optical losses due to absorption of the light by the fluid, by contaminants in the fluid, and/or by the walls of the treatment vessel.
In a fourth embodiment, one or more photodetectors, such as silicon photodiodes or other devices, can be attached to or embedded in treatment vessel walls in order to monitor the flux of UVA radiation within the treatment vessel. Use of window materials and photodetectors suitable for UVA radiation applications allows greater design freedom and lower costs than are practical at the UVC wavelengths traditionally preferred for UV disinfection.
In a fifth embodiment, fluid enters at or near one end of the elongated treatment vessel, flows along the length of the vessel and exits at or near the other end. Ultraviolet radiation from one or more UVA LEDs enters the fluid at one end of the vessel and is transmitted through the fluid along the length of the treatment vessel. Disinfection by the UVA radiation is proportional to the intensity of the radiation and to the dwell time of the flowing fluid within the irradiated portion of the treatment vessel. Making the interior surfaces of the vessel walls reflective—for example by using polished or coated stainless steel walls or by using substantially transparent vessel walls and coating or otherwise adding reflective material to the exterior of the walls—increases the UVA intensity within the fluid and thereby improves disinfection performance. Making the end surfaces of the treatment vessel reflective, except for a window large enough to admit the UVA from the LED or other compact UVA source, recirculates the UV radiation back and forth within the treatment vessel and thereby further increases the UV irradiation flux over the treatment volume. Again, the length of the treatment vessel can be set at the largest practical length to maximize the irradiation time as constrained by absorbance of the fluid and its flow rate through the vessel.
In a sixth embodiment, one or more LEDs or other compact UVA sources can be mounted at each end of a UVA-reflective treatment vessel, to increase the optical flux within the vessel and to improve uniformity of radiation intensity along the length of the treatment vessel.
In a seventh embodiment, the treatment vessel can be shaped or formed at one end or at both ends in order to guide light within the vessel and to reduce the extent of under-illuminated regions in the liquid near a window illuminated by one or more LED or other compact UVA sources outside the vessel. One possible profile of such a shaped or formed vessel end can approximate a parabolic, ellipsoidal or spherical profile. Another possible profile of such a shaped or formed vessel end can be a tapered region, such as a taper with a half-angle of approximately 30-45 degrees, about the axis of the treatment vessel. In addition to guiding light to reduce the extent of under-illuminated regions within the vessel, such a shaped or formed vessel end may also serve to increase reflectivity at the end of the treatment vessel. The detailed profile of such a shaped region can be designed with optical modeling tools to optimize the homogeneity of UV radiation intensity throughout the treatment vessel for the specific emission profile of the one or more UV emitters employed.
In an eighth embodiment, an optical element can be inserted between one or more UVA LEDs or other compact UVA sources and the corresponding window or windows into the treatment vessel. This optical element may incorporate either refractive or reflective features, or both, in order to improve homogeneity of ultraviolet radiation within the treatment vessel, and may also improve optical coupling through at least one window into the treatment vessel.
In a ninth embodiment, an optical element can be formed by or integrated into a window at either or both ends of the treatment vessel. Again, this optical element may serve to improve homogeneity of ultraviolet radiation within the treatment vessel, and may also improve optical coupling through a window into the treatment vessel.
Additional embodiments can be implemented without departing from the spirit or the scope of this disclosure. For example, other combinations of refractive and reflective optical elements can be used to achieve substantially uniform UVA intensity throughout the treatment vessel.
The foregoing and other objects, features, and advantages of the disclosure will become more apparent from the following detailed description, which proceeds with reference to the accompanying figures.
The following is a list of major drawing elements in numerical order:
Referring first to
Referring next to
Referring next to
I=I
0·(1+ρ+ρ2+ρ3+ρ4+ . . . )=I0/(1−ρ). (D-2)
This increase in effective ultraviolet intensity is optimized by making the effective round trip reflectivity ρ2 as large as possible. Use of UVA radiation allows significantly higher UV intensities within the treatment vessel than in a UVC germicidal treatment vessel, because a) UVA LED sources are significantly more powerful than UVC LED sources, b) Material reflectivities are generally higher in the UVA spectral region than in the UVC, and c) UVC absorption in fluids, including water, is generally higher than UVA absorption.
The germicidal UV flux dose FK(λ) required to kill or disable microorganisms in a fluid is wavelength dependent and results in a minimum treatment time τK(λ) at intensity I given by
τK(λ)≧FK(λ)/I. (D-3)
In order to assure all microorganisms are killed or disabled by the treatment system, this minimum dwell time can satisfy the relationship
τDwell≧FK(λ)/I. (D-4)
Through use of reflective materials around or on the exterior surfaces of the treatment vessel, irradiation intensity is increased within the vessel and the length of the treatment vessel can be determined by the absorbance of the fluid being treated.
Referring next to
Referring next to
Referring next to
Referring next to
For a flow rate RFLOW (in cm3 per second) through a vessel with cross-sectional area AV (in cm2) and length LV (in cm), the dwell time in the treatment vessel is approximately
τDwell=α·AV·LV/RFLOW≧FK(λ)/I, (D-5)
where α<1 is a correction factor depending on the flow characteristics of the treatment vessel. Equation D-5 quantifies the advantage of both increased treatment vessel length in maximizing irradiation dwell time within the treatment vessel length and increased UV intensity I in minimizing dwell time required at flow rate RFLOW.
Referring next to
Referring next to
Referring next to
Turning now to
Turning next to
For purposes of this description, certain aspects, advantages, and novel features of the embodiments of this disclosure are described herein. The disclosed methods, apparatuses, and systems should not be construed as limiting in any way. Instead, the present disclosure is directed toward all novel and nonobvious features and aspects of the various disclosed embodiments, alone and in various combinations and sub-combinations with one another. The methods, apparatuses, and systems are not limited to any specific aspect or feature or combination thereof, nor do the disclosed embodiments require that any one or more specific advantages be present or problems be solved.
Although the operations of some of the disclosed methods are described in a particular, sequential order for convenient presentation, it should be understood that this manner of description encompasses rearrangement, unless a particular ordering is required by specific language. For example, operations described sequentially may in some cases be rearranged or performed concurrently. Moreover, for the sake of simplicity, the attached figures may not show the various ways in which the disclosed methods can be used in conjunction with other methods.
As used herein, the terms “a”, “an” and “at least one” encompass one or more of the specified element. That is, if two of a particular element are present, one of these elements is also present and thus “an” element is present. The terms “a plurality of” and “plural” mean two or more of the specified element.
As used herein, the term “and/or” used between the last two of a list of elements means any one or more of the listed elements. For example, the phrase “A, B, and/or C” means “A,” “B,” “C,” “A and B,” “A and C,” “B and C” or “A, B and C.”
As used herein, the term “coupled” generally means physically coupled or linked and does not exclude the presence of intermediate elements between the coupled items absent specific contrary language.
In view of the many possible embodiments to which the principles of the disclosure may be applied, it should be recognized that the illustrated embodiments are only preferred examples and should not be taken as limiting the scope of the disclosure.
This application claims the benefit of U.S. Provisional Patent Application No. 61/649,823, entitled “UVA GERMICIDAL DEVICE” and filed on May 21, 2012, which is incorporated by reference herein in its entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2013/030387 | 3/12/2013 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
61649823 | May 2012 | US |